BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220510T160000
DTEND;TZID=America/Toronto:20220510T170000
DTSTAMP:20260421T024752
CREATED:20220502T190749Z
LAST-MODIFIED:20220502T190749Z
UID:19864-1652198400-1652202000@scienceinboston.com
SUMMARY:Genomic Integration of the SARS-CoV-2 Virus and the Potential Relevance for the Course of COVID-19
DESCRIPTION:In this talk\, Rudolf Jaenisch will summarize the stages of SARS-CoV-2 infection and highlight some puzzling observations. These include the recurrence of PCR-positive tests in patients that have cleared all infectious virus and the long-term complications of the infection (also known as Long-Covid). He will discuss his lab’s evidence for genomic integration of SARS-CoV-2 sequences in cultured cells as well as in patients. One question has been whether vaccine RNA can also integrate into the genome and he will discuss their preliminary results suggesting that vaccine RNA does not integrate.
URL:https://scienceinboston.com/event/genomic-integration-of-the-sars-cov-2-virus-and-the-potential-relevance-for-the-course-of-covid-19/
LOCATION:Whitehead Institute for Biomedical Research\, 455 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220510T160000
DTEND;TZID=America/Toronto:20220510T170000
DTSTAMP:20260421T024752
CREATED:20220502T190749Z
LAST-MODIFIED:20220502T190749Z
UID:27831-1652198400-1652202000@scienceinboston.com
SUMMARY:Genomic Integration of the SARS-CoV-2 Virus and the Potential Relevance for the Course of COVID-19
DESCRIPTION:In this talk\, Rudolf Jaenisch will summarize the stages of SARS-CoV-2 infection and highlight some puzzling observations. These include the recurrence of PCR-positive tests in patients that have cleared all infectious virus and the long-term complications of the infection (also known as Long-Covid). He will discuss his lab’s evidence for genomic integration of SARS-CoV-2 sequences in cultured cells as well as in patients. One question has been whether vaccine RNA can also integrate into the genome and he will discuss their preliminary results suggesting that vaccine RNA does not integrate.
URL:https://scienceinboston.com/event/genomic-integration-of-the-sars-cov-2-virus-and-the-potential-relevance-for-the-course-of-covid-19-2/
LOCATION:Whitehead Institute for Biomedical Research\, 455 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220505T083000
DTEND;TZID=America/Toronto:20220505T203000
DTSTAMP:20260421T024752
CREATED:20220328T182147Z
LAST-MODIFIED:20220425T205410Z
UID:19434-1651739400-1651782600@scienceinboston.com
SUMMARY:2022 State of Possible Conference
DESCRIPTION:MassBio’s annual State of Possible Conference celebrates how the life sciences make the impossible possible. We will tap today’s brightest minds for engaging conversations on the latest developments in our industry\, key insights from the past year\, and building a better future for patients around the world. This year’s conference will explore the theme “The Massachusetts BioPharma Ecosystem in the Post- Covid Era.” \nJoin MassBio and more than 500 attendees for a day of networking\, keynotes\, panel discussions\, and Possible Talks from some of the most inspiring voices in the industry. This is our most popular event so you will want to reserve your spot early.
URL:https://scienceinboston.com/event/2022-state-of-possible-conference/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220505T083000
DTEND;TZID=America/Toronto:20220505T203000
DTSTAMP:20260421T024752
CREATED:20220328T182147Z
LAST-MODIFIED:20220328T182147Z
UID:27822-1651739400-1651782600@scienceinboston.com
SUMMARY:2022 State of Possible Conference
DESCRIPTION:MassBio’s annual State of Possible Conference celebrates how the life sciences make the impossible possible. We will tap today’s brightest minds for engaging conversations on the latest developments in our industry\, key insights from the past year\, and building a better future for patients around the world. This year’s conference will explore the theme “The Massachusetts BioPharma Ecosystem in the Post- Covid Era.” \nJoin MassBio and more than 500 attendees for a day of networking\, keynotes\, panel discussions\, and Possible Talks from some of the most inspiring voices in the industry. This is our most popular event so you will want to reserve your spot early.
URL:https://scienceinboston.com/event/2022-state-of-possible-conference-2/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220429T100000
DTEND;TZID=America/Toronto:20220429T170000
DTSTAMP:20260421T024752
CREATED:20220209T211903Z
LAST-MODIFIED:20220209T211903Z
UID:18745-1651226400-1651251600@scienceinboston.com
SUMMARY:Annual MIT Microbiome Symposium 2022
DESCRIPTION:The MIT Center for Microbiome Informatics and Therapeutics and the MIT Microbiome Club are proud to invite you to participate in our annual MIT Microbiome Symposium to be held on Friday\, April 29\, 2022 from 10 am-5 pm ET at the MIT Media Lab (E15). \nThe symposium will feature talks from established and young investigators\, poster sessions\, industry representatives\, and a networking social to close the symposium. For more details\, please check out the Microbiome Symposium website. This year we are proud to host Dr. Gretchen Diehl (Memorial Sloan Kettering) and Dr. Elizabeth Johnson (Cornell University) as our two keynote speakers. \nAbstract submission is currently open on our website and will end on March 11\, 2022. \nRegistration (free) for both the in-person event and livestream will open in March!
URL:https://scienceinboston.com/event/annual-mit-microbiome-symposium-2022/
LOCATION:MIT Media Lab\, 75 Amherst St\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220429T100000
DTEND;TZID=America/Toronto:20220429T170000
DTSTAMP:20260421T024752
CREATED:20220209T211903Z
LAST-MODIFIED:20220209T211903Z
UID:27805-1651226400-1651251600@scienceinboston.com
SUMMARY:Annual MIT Microbiome Symposium 2022
DESCRIPTION:The MIT Center for Microbiome Informatics and Therapeutics and the MIT Microbiome Club are proud to invite you to participate in our annual MIT Microbiome Symposium to be held on Friday\, April 29\, 2022 from 10 am-5 pm ET at the MIT Media Lab (E15). \nThe symposium will feature talks from established and young investigators\, poster sessions\, industry representatives\, and a networking social to close the symposium. For more details\, please check out the Microbiome Symposium website. This year we are proud to host Dr. Gretchen Diehl (Memorial Sloan Kettering) and Dr. Elizabeth Johnson (Cornell University) as our two keynote speakers. \nAbstract submission is currently open on our website and will end on March 11\, 2022. \nRegistration (free) for both the in-person event and livestream will open in March!
URL:https://scienceinboston.com/event/annual-mit-microbiome-symposium-2022-2/
LOCATION:MIT Media Lab\, 75 Amherst St\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220427T163000
DTEND;TZID=America/Toronto:20220427T190000
DTSTAMP:20260421T024752
CREATED:20220404T024049Z
LAST-MODIFIED:20220404T024049Z
UID:19477-1651077000-1651086000@scienceinboston.com
SUMMARY:Tufts@Kendall: Advances in Immunology and Inflammation
DESCRIPTION:In an intricate balance\, the immune system and its responses are at the intersection of health and disease. Discover how Tufts investigators are at the forefront of immunologic\, tissue\, organ-based and age-related research to improve and enhance human health. Join us for a poster session & networking event to learn more about our research and collaboration opportunities in the areas of immunology and inflammation. \n\n\nConnect with our experts to discuss their advances in acute and chronic inflammation\, inflammaging\, autoimmune diseases\, cardiovascular disease\, adaptive and innate immunity\, disease modeling\, biomaterials\, tissue engineering\, and more.
URL:https://scienceinboston.com/event/tuftskendall-advances-in-immunology-and-inflammation/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220427T163000
DTEND;TZID=America/Toronto:20220427T190000
DTSTAMP:20260421T024752
CREATED:20220404T024049Z
LAST-MODIFIED:20220404T024049Z
UID:27825-1651077000-1651086000@scienceinboston.com
SUMMARY:Tufts@Kendall: Advances in Immunology and Inflammation
DESCRIPTION:In an intricate balance\, the immune system and its responses are at the intersection of health and disease. Discover how Tufts investigators are at the forefront of immunologic\, tissue\, organ-based and age-related research to improve and enhance human health. Join us for a poster session & networking event to learn more about our research and collaboration opportunities in the areas of immunology and inflammation. \n\n\nConnect with our experts to discuss their advances in acute and chronic inflammation\, inflammaging\, autoimmune diseases\, cardiovascular disease\, adaptive and innate immunity\, disease modeling\, biomaterials\, tissue engineering\, and more.
URL:https://scienceinboston.com/event/tuftskendall-advances-in-immunology-and-inflammation-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220427T080000
DTEND;TZID=America/Toronto:20220427T100000
DTSTAMP:20260421T024752
CREATED:20220404T024213Z
LAST-MODIFIED:20220404T032245Z
UID:19480-1651046400-1651053600@scienceinboston.com
SUMMARY:Turning Great Ideas into Dollars: The Life-Cycle of a Start-Up - Part One
DESCRIPTION:Tech Transfer: When and How an Idea Moves Out of Academia\nJoin us for the first event of a three-part series exploring the best approach for independent early-stage entrepreneurs and biotechs to get funding at various stages. \nFor pharmaceutical and life science companies\, establishing successful collaborations with academic labs goes beyond identifying the right principal investigator (PI) or technology. These companies must also strategically and effectively engage with technology transfer offices to establish sponsored research agreements and license the appropriate technology. This panel of experts will break down the process and share their hands-on experience with tech transfer and licensing. \n8:00 AM – 9:00 AM\nNetworking \n9:00 AM – 10:00 AM\nPanel Discussion
URL:https://scienceinboston.com/event/turning-great-ideas-into-dollars-the-life-cycle-of-a-start-up-part-one/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220427T080000
DTEND;TZID=America/Toronto:20220427T100000
DTSTAMP:20260421T024752
CREATED:20220404T024213Z
LAST-MODIFIED:20220404T024213Z
UID:27826-1651046400-1651053600@scienceinboston.com
SUMMARY:Turning Great Ideas into Dollars: The Life-Cycle of a Start-Up - Part One
DESCRIPTION:Tech Transfer: When and How an Idea Moves Out of Academia\nJoin us for the first event of a three-part series exploring the best approach for independent early-stage entrepreneurs and biotechs to get funding at various stages. \nFor pharmaceutical and life science companies\, establishing successful collaborations with academic labs goes beyond identifying the right principal investigator (PI) or technology. These companies must also strategically and effectively engage with technology transfer offices to establish sponsored research agreements and license the appropriate technology. This panel of experts will break down the process and share their hands-on experience with tech transfer and licensing. \n8:00 AM – 9:00 AM\nNetworking \n9:00 AM – 10:00 AM\nPanel Discussion
URL:https://scienceinboston.com/event/turning-great-ideas-into-dollars-the-life-cycle-of-a-start-up-part-one-2/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220422T120000
DTEND;TZID=America/Vancouver:20220422T130000
DTSTAMP:20260421T024752
CREATED:20220418T193630Z
LAST-MODIFIED:20220418T193649Z
UID:19709-1650628800-1650632400@scienceinboston.com
SUMMARY:Stephen Quake Presentation: "A Decade of Molecular Cell Atlases"
DESCRIPTION:Join us as we welcome Dr. Quake (Stanford and Chan Zuckerberg Biohub) for a presentation on “A Decade of Molecular Cell Atlases” \nRestricted to MIT community.
URL:https://scienceinboston.com/event/stephen-quake-presentation-a-decade-of-molecular-cell-atlases/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220422T120000
DTEND;TZID=America/Vancouver:20220422T130000
DTSTAMP:20260421T024752
CREATED:20220418T193630Z
LAST-MODIFIED:20220418T193630Z
UID:27828-1650628800-1650632400@scienceinboston.com
SUMMARY:Stephen Quake Presentation: "A Decade of Molecular Cell Atlases"
DESCRIPTION:Join us as we welcome Dr. Quake (Stanford and Chan Zuckerberg Biohub) for a presentation on “A Decade of Molecular Cell Atlases” \nRestricted to MIT community.
URL:https://scienceinboston.com/event/stephen-quake-presentation-a-decade-of-molecular-cell-atlases-2/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220413T123000
DTEND;TZID=America/Toronto:20220413T133000
DTSTAMP:20260421T024752
CREATED:20220407T163458Z
LAST-MODIFIED:20220407T163458Z
UID:19573-1649853000-1649856600@scienceinboston.com
SUMMARY:A Macro View of Microdosing
DESCRIPTION:Microdosing psychedelics involves consuming doses that are one-twentieth to one-tenth the size of standard doses. The practice has become increasingly popular among individuals seeking to boost their productivity\, elevate their mood\, or treat symptoms of depression\, anxiety\, or pain. The increasing use of microdosing has inspired media coverage and scientific analysis of its costs and benefits. On April 13\, POPLAR will gather experts on the science\, law\, and business of microdosing for a panel discussion accompanied by a digital symposium on the Bill of Health. After a keynote address by Dr. James Fadiman\, a longtime microdosing scholar and advocate\, the event will turn to a panel discussion of the promise\, risks\, and future of microdosing psychedelics. \nPanelists\nIntroduction: Carmel Shachar\, Executive Director\, The Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School \nSarah Hashkes\, Co-Founder & CEO\, Radix Motion; Chief Technology Innovation Officer\, Red Light Holland \nDave Kopilak\, Shareholder\, Emerge Law Group \nErin Sharoni\, Chief Product Officer\, FOXO Technologies; Candidate for Master of Bioethics\, Harvard Medical School \nIfetayo Harvey\, Founder\, People of Color Psychedelic Collective \nModerator: Mason Marks\, MD\, JD\, Assistant Professor of Law\, University of New Hampshire Franklin Pierce School of Law; Senior Fellow and Project Lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School \nSponsored by the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School.
URL:https://scienceinboston.com/event/a-macro-view-of-microdosing/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220413T123000
DTEND;TZID=America/Toronto:20220413T133000
DTSTAMP:20260421T024752
CREATED:20220407T163458Z
LAST-MODIFIED:20220407T163458Z
UID:27827-1649853000-1649856600@scienceinboston.com
SUMMARY:A Macro View of Microdosing
DESCRIPTION:Microdosing psychedelics involves consuming doses that are one-twentieth to one-tenth the size of standard doses. The practice has become increasingly popular among individuals seeking to boost their productivity\, elevate their mood\, or treat symptoms of depression\, anxiety\, or pain. The increasing use of microdosing has inspired media coverage and scientific analysis of its costs and benefits. On April 13\, POPLAR will gather experts on the science\, law\, and business of microdosing for a panel discussion accompanied by a digital symposium on the Bill of Health. After a keynote address by Dr. James Fadiman\, a longtime microdosing scholar and advocate\, the event will turn to a panel discussion of the promise\, risks\, and future of microdosing psychedelics. \nPanelists\nIntroduction: Carmel Shachar\, Executive Director\, The Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School \nSarah Hashkes\, Co-Founder & CEO\, Radix Motion; Chief Technology Innovation Officer\, Red Light Holland \nDave Kopilak\, Shareholder\, Emerge Law Group \nErin Sharoni\, Chief Product Officer\, FOXO Technologies; Candidate for Master of Bioethics\, Harvard Medical School \nIfetayo Harvey\, Founder\, People of Color Psychedelic Collective \nModerator: Mason Marks\, MD\, JD\, Assistant Professor of Law\, University of New Hampshire Franklin Pierce School of Law; Senior Fellow and Project Lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School \nSponsored by the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School.
URL:https://scienceinboston.com/event/a-macro-view-of-microdosing-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220411T170000
DTEND;TZID=America/Vancouver:20220411T183000
DTSTAMP:20260421T024752
CREATED:20220404T194446Z
LAST-MODIFIED:20220404T194446Z
UID:19471-1649696400-1649701800@scienceinboston.com
SUMMARY:MIT Research Slam & 3 Minute Thesis
DESCRIPTION:Learn about cool research across MIT and celebrate inspiring communicators! Register to attend the MIT Research Slam Showcase\, a research communication competition for MIT Ph.D. students and postdocs. The showcase will feature 3-minute videos\, where participants explain their research and its significance in an engaging way to a general audience! \nThe program will include live viewing of finalist videos and evaluation by an expert panel of judges. Attendees can join in the fun and contribute their vote for the audience-choice awards\, as well as ask questions and leave comments. Come support MIT students and postdocs as they polish the important skill of communicating their research in a clear and concise manner. \nRegistration is open to the general public\, so help us spread the word at MIT and beyond! \nRegistration link: https://mit.zoom.us/webinar/register/WN_8qr3GQbJR82PnQl9ap6WqA
URL:https://scienceinboston.com/event/mit-research-slam-3-minute-thesis/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/04/2-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220411T170000
DTEND;TZID=America/Vancouver:20220411T183000
DTSTAMP:20260421T024752
CREATED:20220404T194446Z
LAST-MODIFIED:20220404T194446Z
UID:27824-1649696400-1649701800@scienceinboston.com
SUMMARY:MIT Research Slam & 3 Minute Thesis
DESCRIPTION:Learn about cool research across MIT and celebrate inspiring communicators! Register to attend the MIT Research Slam Showcase\, a research communication competition for MIT Ph.D. students and postdocs. The showcase will feature 3-minute videos\, where participants explain their research and its significance in an engaging way to a general audience! \nThe program will include live viewing of finalist videos and evaluation by an expert panel of judges. Attendees can join in the fun and contribute their vote for the audience-choice awards\, as well as ask questions and leave comments. Come support MIT students and postdocs as they polish the important skill of communicating their research in a clear and concise manner. \nRegistration is open to the general public\, so help us spread the word at MIT and beyond! \nRegistration link: https://mit.zoom.us/webinar/register/WN_8qr3GQbJR82PnQl9ap6WqA
URL:https://scienceinboston.com/event/mit-research-slam-3-minute-thesis-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/04/2-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220408T120000
DTEND;TZID=America/Toronto:20220408T160000
DTSTAMP:20260421T024752
CREATED:20220325T173329Z
LAST-MODIFIED:20220325T173329Z
UID:19379-1649419200-1649433600@scienceinboston.com
SUMMARY:2022 MIT Biotech Group Career Fair
DESCRIPTION:The MIT Biotech Group Career Fair is a one-day virtual event providing a platform for companies in the biotech\, biopharma\, medtech\, consulting\, IP/Law\, and VC/Finance spaces to connect with talent within the biotech community. The fair is a cross-MIT collaboration\, hosted by the MIT Biotech Group\, in partnership with the MIT Departments of Biology\, Biological Engineering\, Chemical Engineering\, Brain & Cognitive Sciences\, the Program of Health Sciences & Technology\, Computational & Systems Biology\, and the Institute for Medical Engineering and Science at MIT.
URL:https://scienceinboston.com/event/2022-mit-biotech-group-career-fair/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220408T120000
DTEND;TZID=America/Toronto:20220408T160000
DTSTAMP:20260421T024752
CREATED:20220325T173329Z
LAST-MODIFIED:20220325T173329Z
UID:27821-1649419200-1649433600@scienceinboston.com
SUMMARY:2022 MIT Biotech Group Career Fair
DESCRIPTION:The MIT Biotech Group Career Fair is a one-day virtual event providing a platform for companies in the biotech\, biopharma\, medtech\, consulting\, IP/Law\, and VC/Finance spaces to connect with talent within the biotech community. The fair is a cross-MIT collaboration\, hosted by the MIT Biotech Group\, in partnership with the MIT Departments of Biology\, Biological Engineering\, Chemical Engineering\, Brain & Cognitive Sciences\, the Program of Health Sciences & Technology\, Computational & Systems Biology\, and the Institute for Medical Engineering and Science at MIT.
URL:https://scienceinboston.com/event/2022-mit-biotech-group-career-fair-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220405T153000
DTEND;TZID=America/Toronto:20220405T183000
DTSTAMP:20260421T024752
CREATED:20220328T182245Z
LAST-MODIFIED:20220328T182245Z
UID:19437-1649172600-1649183400@scienceinboston.com
SUMMARY:Astellas Pharma Day
DESCRIPTION:Accelerate your biotech company\, startup\, or university’s innovation portfolio at our Astellas 2022 Pharma Day on April 5. \nMassBio’s Pharma Days® are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. \nDiscover on April 5 | Join Astellas’ open information session on April 5 for the latest insights on its R&D strategy\, target therapeutic areas\, and partnering capabilities. This session will be followed by a networking reception. This session will feature: \n\nHide Goto\, Ph.D.\, President\, Astellas Institute for Regenerative Medicine\nMichael Luther\, Ph.D.\, MBA\, Head of Early Stage Partnering\, Astellas\nMichael Patane\, Ph.D.\, President\, Mitobridge\nMat Pletcher\, Ph.D.\, Division Head of Gene Therapy Research & Technical Operations\, Astellas Gene Therapies\nJoanna Stanicka\, Ph.D.\, CEO and Founder\, Axonis
URL:https://scienceinboston.com/event/astellas-pharma-day-2/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220405T153000
DTEND;TZID=America/Toronto:20220405T183000
DTSTAMP:20260421T024752
CREATED:20220328T182245Z
LAST-MODIFIED:20220328T182245Z
UID:27823-1649172600-1649183400@scienceinboston.com
SUMMARY:Astellas Pharma Day
DESCRIPTION:Accelerate your biotech company\, startup\, or university’s innovation portfolio at our Astellas 2022 Pharma Day on April 5. \nMassBio’s Pharma Days® are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. \nDiscover on April 5 | Join Astellas’ open information session on April 5 for the latest insights on its R&D strategy\, target therapeutic areas\, and partnering capabilities. This session will be followed by a networking reception. This session will feature: \n\nHide Goto\, Ph.D.\, President\, Astellas Institute for Regenerative Medicine\nMichael Luther\, Ph.D.\, MBA\, Head of Early Stage Partnering\, Astellas\nMichael Patane\, Ph.D.\, President\, Mitobridge\nMat Pletcher\, Ph.D.\, Division Head of Gene Therapy Research & Technical Operations\, Astellas Gene Therapies\nJoanna Stanicka\, Ph.D.\, CEO and Founder\, Axonis
URL:https://scienceinboston.com/event/astellas-pharma-day-2-2/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220331T100000
DTEND;TZID=America/Vancouver:20220331T140000
DTSTAMP:20260421T024752
CREATED:20220204T230136Z
LAST-MODIFIED:20220307T173104Z
UID:18649-1648720800-1648735200@scienceinboston.com
SUMMARY:13th Annual Prostate Cancer Awareness Day
DESCRIPTION:Join leaders of legislature\, medicine and advocacy for the 13th Annual Prostate Cancer Awareness Day (PCAD) on March 31\, 2022\, between 10 am and 2 pm. It is organized by AdMeTech Foundation in cooperation with Prostate Cancer Action Council – and will be held virtually (prior to pandemic\, it has taken place at the Massachusetts State House since 2009). This event has created a Massachusetts model of national leadership in prostate cancer education and awareness since 2011\, when the state legislature had set a historic precedent by recognizing prostate cancer as a public health priority and leading health disparity in Black men. This year\, AdMeTech will announce launching a Prostate Cancer Equity Program to bring high quality care to every man. For more information\, visit www.admetech.org.
URL:https://scienceinboston.com/event/13th-annual-prostate-cancer-awareness-day/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/02/PCAD-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220331T100000
DTEND;TZID=America/Vancouver:20220331T140000
DTSTAMP:20260421T024752
CREATED:20220204T230136Z
LAST-MODIFIED:20220204T230136Z
UID:27804-1648720800-1648735200@scienceinboston.com
SUMMARY:13th Annual Prostate Cancer Awareness Day
DESCRIPTION:Join leaders of legislature\, medicine and advocacy for the 13th Annual Prostate Cancer Awareness Day (PCAD) on March 31\, 2022\, between 10 am and 2 pm. It is organized by AdMeTech Foundation in cooperation with Prostate Cancer Action Council – and will be held virtually (prior to pandemic\, it has taken place at the Massachusetts State House since 2009). This event has created a Massachusetts model of national leadership in prostate cancer education and awareness since 2011\, when the state legislature had set a historic precedent by recognizing prostate cancer as a public health priority and leading health disparity in Black men. This year\, AdMeTech will announce launching a Prostate Cancer Equity Program to bring high quality care to every man. For more information\, visit www.admetech.org.
URL:https://scienceinboston.com/event/13th-annual-prostate-cancer-awareness-day-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/02/PCAD-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220330T110000
DTEND;TZID=America/Toronto:20220330T125000
DTSTAMP:20260421T024752
CREATED:20220314T060621Z
LAST-MODIFIED:20220321T175433Z
UID:19224-1648638000-1648644600@scienceinboston.com
SUMMARY:Careers in Academia for Biomedical Students: Panel
DESCRIPTION:Now what? “I’m in a biomedical training program so I’m committed to a career in the biomedical sciences but frankly\, I’m not sure exactly what I want to do with my PhD/postdoctoral training. Actually\, I’m not even sure I know what’s out there!” Could this be you? If so\, you might want to join us to learn more about the biomedical workforce opportunities from those doing the work. We’re holding a series of panel discussions that will enable you to learn about various career opportunities\, in many cases through the lenses of our Boston University alumni. Don’t limit yourself as you might be surprised to learn about career paths you had not considered! \nRegistration: https://bostonu.zoom.us/meeting/register/tJcvcOmpqDsuHte6ihkvNJV-YNCC9Q6qd_Tr
URL:https://scienceinboston.com/event/careers-in-academia-for-biomedical-students-panel/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220330T110000
DTEND;TZID=America/Toronto:20220330T125000
DTSTAMP:20260421T024752
CREATED:20220314T060621Z
LAST-MODIFIED:20220314T060621Z
UID:27820-1648638000-1648644600@scienceinboston.com
SUMMARY:Careers in Academia for Biomedical Students: Panel
DESCRIPTION:Now what? “I’m in a biomedical training program so I’m committed to a career in the biomedical sciences but frankly\, I’m not sure exactly what I want to do with my PhD/postdoctoral training. Actually\, I’m not even sure I know what’s out there!” Could this be you? If so\, you might want to join us to learn more about the biomedical workforce opportunities from those doing the work. We’re holding a series of panel discussions that will enable you to learn about various career opportunities\, in many cases through the lenses of our Boston University alumni. Don’t limit yourself as you might be surprised to learn about career paths you had not considered! \nRegistration: https://bostonu.zoom.us/meeting/register/tJcvcOmpqDsuHte6ihkvNJV-YNCC9Q6qd_Tr
URL:https://scienceinboston.com/event/careers-in-academia-for-biomedical-students-panel-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220329T173000
DTEND;TZID=America/Toronto:20220329T183000
DTSTAMP:20260421T024752
CREATED:20220314T054913Z
LAST-MODIFIED:20220314T203412Z
UID:19210-1648575000-1648578600@scienceinboston.com
SUMMARY:SCIENCE with/in/sight: How Are Cancer Researchers Fighting COVID-19?
DESCRIPTION:The Koch Institute for Integrative Cancer Research at MIT cordially invites you to attend SCIENCE with/in/sight: How Are Cancer Researchers Fighting COVID-19? showcasing the work of MIT faculty and clinical investigators to address urgent and pressing needs related to the COVID-19 pandemic. \nThe third in a series of COVID-specific with/in/sight events\, this evening’s program will present updates from three projects begun in Spring 2020. \nPresenters: \nAngela Belcher\, PhD\nNovel materials for PPE\nJames Mason Crafts Professor; Head\, MIT Department of Biological Engineering \nMichael Yaffe\, MD\, PhD\nOvercoming respiratory distress\nDavid H. Koch Professor of Science; Intensive Care Physician\, Beth Israel Deaconess Medical Center \nHojun Li\, MD\, PhD\nOn-demand protective immunity testing\nCharles W. (1955) and Jennifer C. Johnson Clinical Investigator \nModerated by Jane Wilkinson\nExecutive Director\, Koch Institute at MIT \nTo register for in-person attendance visit https://www.eventbrite.com/e/272732118107 \nTo register for virtual attendance\, visit https://mit.zoom.us/webinar/register/WN_eSCrGGkLSmSRMQl_k3DC7A
URL:https://scienceinboston.com/event/science-with-in-sight-how-are-cancer-researchers-fighting-covid-19/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220329T173000
DTEND;TZID=America/Toronto:20220329T183000
DTSTAMP:20260421T024752
CREATED:20220314T054913Z
LAST-MODIFIED:20220314T054913Z
UID:27816-1648575000-1648578600@scienceinboston.com
SUMMARY:SCIENCE with/in/sight: How Are Cancer Researchers Fighting COVID-19?
DESCRIPTION:The Koch Institute for Integrative Cancer Research at MIT cordially invites you to attend SCIENCE with/in/sight: How Are Cancer Researchers Fighting COVID-19? showcasing the work of MIT faculty and clinical investigators to address urgent and pressing needs related to the COVID-19 pandemic. \nThe third in a series of COVID-specific with/in/sight events\, this evening’s program will present updates from three projects begun in Spring 2020. \nPresenters: \nAngela Belcher\, PhD\nNovel materials for PPE\nJames Mason Crafts Professor; Head\, MIT Department of Biological Engineering \nMichael Yaffe\, MD\, PhD\nOvercoming respiratory distress\nDavid H. Koch Professor of Science; Intensive Care Physician\, Beth Israel Deaconess Medical Center \nHojun Li\, MD\, PhD\nOn-demand protective immunity testing\nCharles W. (1955) and Jennifer C. Johnson Clinical Investigator \nModerated by Jane Wilkinson\nExecutive Director\, Koch Institute at MIT \nTo register for in-person attendance visit https://www.eventbrite.com/e/272732118107 \nTo register for virtual attendance\, visit https://mit.zoom.us/webinar/register/WN_eSCrGGkLSmSRMQl_k3DC7A
URL:https://scienceinboston.com/event/science-with-in-sight-how-are-cancer-researchers-fighting-covid-19-2/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220324T140000
DTEND;TZID=America/Toronto:20220324T150000
DTSTAMP:20260421T024752
CREATED:20220221T191046Z
LAST-MODIFIED:20220221T191046Z
UID:18925-1648130400-1648134000@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Diana Brainard\, AlloVir
DESCRIPTION:Diana Brainard\, MD\, is CEO of AlloVir\, a late-stage cell therapy company focused on developing innovative\, allogeneic\, off-the-shelf\, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases. She has more than 20 years of experience in the biopharmaceutical industry and academic medicine\, has authored more than 200 publications\, and brings a passion for advancing therapies for devastating diseases. \nPreviously\, Dr. Brainard spent more than a decade at Gilead\, where she played an enterprise-wide leadership role as the head of the virology therapeutic area overseeing the development and launch of some of the most successful drugs of the last decade including Sovaldi\, Harvoni\, Epclusa\, and Biktarvy. In 2020\, she led the company-wide initiative to rapidly advance remdesivir to become the first and only antiviral to receive regulatory approval for the treatment of SARS-CoV-2\, which earned her global recognition as one of the most influential people in the fight against SARS-CoV-2. Her industry career began at Merck\, where she held positions in clinical pharmacology and experimental medicine. \nDr. Brainard received her MD from Tulane University School of Medicine\, and her BA in comparative literature from Brown University. Following completion of her medical training\, she was on the faculty at Harvard Medical School\, where her NIH-funded research focused on HIV immunology and T-cell trafficking.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-diana-brainard-allovir/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220324T140000
DTEND;TZID=America/Toronto:20220324T150000
DTSTAMP:20260421T024752
CREATED:20220221T191046Z
LAST-MODIFIED:20220221T191046Z
UID:27812-1648130400-1648134000@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Diana Brainard\, AlloVir
DESCRIPTION:Diana Brainard\, MD\, is CEO of AlloVir\, a late-stage cell therapy company focused on developing innovative\, allogeneic\, off-the-shelf\, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases. She has more than 20 years of experience in the biopharmaceutical industry and academic medicine\, has authored more than 200 publications\, and brings a passion for advancing therapies for devastating diseases. \nPreviously\, Dr. Brainard spent more than a decade at Gilead\, where she played an enterprise-wide leadership role as the head of the virology therapeutic area overseeing the development and launch of some of the most successful drugs of the last decade including Sovaldi\, Harvoni\, Epclusa\, and Biktarvy. In 2020\, she led the company-wide initiative to rapidly advance remdesivir to become the first and only antiviral to receive regulatory approval for the treatment of SARS-CoV-2\, which earned her global recognition as one of the most influential people in the fight against SARS-CoV-2. Her industry career began at Merck\, where she held positions in clinical pharmacology and experimental medicine. \nDr. Brainard received her MD from Tulane University School of Medicine\, and her BA in comparative literature from Brown University. Following completion of her medical training\, she was on the faculty at Harvard Medical School\, where her NIH-funded research focused on HIV immunology and T-cell trafficking.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-diana-brainard-allovir-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220323T130000
DTEND;TZID=America/Vancouver:20220323T140000
DTSTAMP:20260421T024752
CREATED:20220314T055727Z
LAST-MODIFIED:20220314T055727Z
UID:19221-1648040400-1648044000@scienceinboston.com
SUMMARY:Finding Funding for Pediatric Medical Research: Meet the Thrasher Research Fund
DESCRIPTION:Looking for funding for pediatric medical research? Join this virtual workshop to learn more about the Thrasher Research Fund\, located in Salt Lake City\, which supports science that advances the diagnosis and treatment of children’s diseases. Thrasher currently funds research on childhood blindness\, nutritional deficiencies\, brain injuries\, diabetes\, asthma\, cancer\, genetic diseases\, and infectious diseases such as HIV\, malaria\, and tuberculosis. The fund favors projects that have strong potential for near-term clinical translation. \nThrasher holds two competitions per year for two separate grant programs: Thrasher Early Career Awards (offering grants of $25k) and\, for investigators at all career levels\, E.W. “Al” Thrasher Awards (offering grants of up to $500k). Distinctively\, Thrasher allows their awards to be used to supplement another grant and it funds both domestic and international projects. \nRegistration: https://www.bu.edu/research/featured-events/research-how-to-events/meet-the-thrasher-research-fund/
URL:https://scienceinboston.com/event/finding-funding-for-pediatric-medical-research-meet-the-thrasher-research-fund/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220323T130000
DTEND;TZID=America/Vancouver:20220323T140000
DTSTAMP:20260421T024752
CREATED:20220314T055727Z
LAST-MODIFIED:20220314T055727Z
UID:27819-1648040400-1648044000@scienceinboston.com
SUMMARY:Finding Funding for Pediatric Medical Research: Meet the Thrasher Research Fund
DESCRIPTION:Looking for funding for pediatric medical research? Join this virtual workshop to learn more about the Thrasher Research Fund\, located in Salt Lake City\, which supports science that advances the diagnosis and treatment of children’s diseases. Thrasher currently funds research on childhood blindness\, nutritional deficiencies\, brain injuries\, diabetes\, asthma\, cancer\, genetic diseases\, and infectious diseases such as HIV\, malaria\, and tuberculosis. The fund favors projects that have strong potential for near-term clinical translation. \nThrasher holds two competitions per year for two separate grant programs: Thrasher Early Career Awards (offering grants of $25k) and\, for investigators at all career levels\, E.W. “Al” Thrasher Awards (offering grants of up to $500k). Distinctively\, Thrasher allows their awards to be used to supplement another grant and it funds both domestic and international projects. \nRegistration: https://www.bu.edu/research/featured-events/research-how-to-events/meet-the-thrasher-research-fund/
URL:https://scienceinboston.com/event/finding-funding-for-pediatric-medical-research-meet-the-thrasher-research-fund-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR